Growth Metrics

Resmed (RMD) Non-Current Deferred Tax Liability (2016 - 2025)

Resmed's Non-Current Deferred Tax Liability history spans 16 years, with the latest figure at $78.0 million for Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability rose 1.29% year-over-year to $78.0 million; the TTM value through Dec 2025 reached $78.0 million, up 1.29%, while the annual FY2025 figure was $77.7 million, 2.09% down from the prior year.
  • Non-Current Deferred Tax Liability reached $78.0 million in Q4 2025 per RMD's latest filing, up from $77.6 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $113.0 million in Q1 2023 to a low of $9.7 million in Q2 2022.
  • Average Non-Current Deferred Tax Liability over 5 years is $60.4 million, with a median of $77.8 million recorded in 2025.
  • Peak YoY movement for Non-Current Deferred Tax Liability: plummeted 50.97% in 2021, then surged 955.13% in 2023.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $12.9 million in 2021, then surged by 735.39% to $107.5 million in 2022, then dropped by 16.98% to $89.3 million in 2023, then dropped by 13.75% to $77.0 million in 2024, then increased by 1.29% to $78.0 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Non-Current Deferred Tax Liability are $78.0 million (Q4 2025), $77.6 million (Q3 2025), and $77.7 million (Q2 2025).